Diagnosis & Disease Information

ZYDELIG® (idelalisib) for Relapsed Chronic Lymphocytic Leukemia

This slideshow reviews drug information for ZYDELIG® (idelalisib), indicated for relapsed chronic lymphoma. Table of Contents Slide 3: Indication, Dosage, and AdministrationSlide 7: Use in Specific PopulationsSlide 9: Clinical PharmacologySlide 13: Warnings and PrecautionsSlide 18: Clinical Safety and EfficacySlide 24: Drug Storage and SupplySlide 26: References

Next post in Lymphoma